Long-Term Open-Label Extension Study of Oral Levosimendan
Long-Term Open-Label Extension Study of Oral Levosimendan
Enrolling by invitation · NCT07436689 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Open-Label Extension Study of Oral Levosimendan | cardiovascular disorder, heart disorder, heart failure | Enrolling by invitation | Phase 3 | 2026-09-09 | NCT07436689 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tenax Therapeutics, Inc. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||